Issue link: http://osercommunicationsgroup.uberflip.com/i/709458
C h a i n D r u g s t o r e D a i l y 1 9 Tu e s d a y, A u g u s t 9 , 2 0 1 6 NEXCARE SENSITIVE SKIN PRODUCTS OFFER OPTIONS More than 70 percent of Americans report being bothered by skin sensitivity, according to new research by Nexcare Brand. Scrapes, bumps, scratches and bruises are often a by-product of outdoor fun year round. Most people can proba- bly slap on a bandage and go about their business, but if you have sensitive skin, the adhesives in many over-the-counter first aid products can cause skin irrita- tion. Forty-three percent of Americans reported avoiding an activity due to a skin problem – including using a specific beauty product, eating or drinking certain foods, wearing their favorite clothes, using particular blankets and linens or applying first aid supplies and medical tape. "Sensitive skin is an important focus for the Nexcare Brand, as we've found that skin sensitivity affects children, mil- lennials, baby boomers, caregivers and parents alike, and our line of products offers an option for those bothered by sensitive skin issues," says Carrie Sazama, Brand Manager, Nexcare Brand. Look for first aid prod- ucts that are designed for sen- sitive skin, such as the Sensitive Skin collection by Nexcare Brand. These prod- ucts are formulated to reliably stick to skin and are easy to remove. The product line includes bandages, first aid tape and adhesive pads with hypoallergenic adhesive. They adhere firmly, yet remove cleanly and easily with minimal hair pulling. With reliable adhesion and pain-free removal, these products offer an option for those with skin sensitivity. The Nexcare Sensitive Skin line is priced from $2.99 and is avail- able at select retail stores nation- wide. For additional information and to locate a retailer, visit www.nexcare.com/sensitiveskin. About 3M 3M applies science in collabo- rative ways to improve lives daily. With $32 billion in sales, its 90,000 employees connect with customers all around the world. Learn more about 3M's creative solu- tions to the world's problems at www.3M.com or on Twitter @3M or @3MNewsroom. For more information, visit booth #1131. TREAT YOUR HANDS AS WELL AS YOU TREAT YOUR FACE WITH HAND MD Thanks to advancements in anti-aging products, your face may no longer reveal your true age. However, studies show that most people can accurately tell a woman's age just by looking at her hands. The hands are truly the work hors- es of the body. They are under constant attack by the elements since they are the part of the body most exposed to harsh ingredients, chemicals and the sun. Even just hand-washing can strip away the nat- ural oils and dry out your hands. As a result, your hands not only tend to be more susceptible to the first signs of aging, but very often age even faster than the face. There is very little fat in the back of the hands, so the normal aging process is going to have a noticeable impact on your hands. Hand MD™ is the first anti-aging brand developed specifically to rejuve- nate and protect aging, dry hands. Hand creams and lotions only work to tem- porarily moisturize the surface of the hands, but are not designed to rejuvenate the hands. While there are countless serums, moisturizers, peels and other treatments for a woman's face, there are no other anti-aging product specifically formulated for the hands. "Hand MD will revolutionize the anti-aging category by addressing an unmet need," said Jack Ross, Chief Executive Officer of Synergy CHC Corp., whose company acquired Hand MD in late 2015. One of the core products in the line is Hand MD Restorative DUO that delivers two formulations (dual pump application) that layer togeth- er for a synergistic, age-defy- ing treatment that helps revi- talize and repair aging, dry hands. The anti-aging serum is applied first to deeply pen- etrate and repair the skin with a unique combination of anti- aging ingredients including Retinol and powerful peptides. The antioxidant-rich moisturizing cream is applied second and works to seal the rejuvenating serum as it nourishes the skin. Clinical studies revealed that 84 percent of the women in the study group experienced a reduction in fine lines and wrinkles, while 100 per- cent saw significant improvement in skin hydration after eight weeks of use. Hand MD also features a Daily Renewal Protection Cream, which offers a broad spectrum SPF 30+ sun protection plus hydration with an exclusive age- defying blend of turmeric, caffeine and niacinamide to promote cell renewal and the appearance of younger-looking skin. The lat- est additions to the Hand MD family include an Exfoliating Peel Cream and a Moisturizing Nourishing Cream. The brand has been featured on QVC during "The Lisa Robertson Show" several times where it sold out in the first 10 minutes of the program. "With this type of proven success, we look forward to rolling out the Hand MD line into retail over the next several months," added Ross. In order to look your best, you need to treat your hands as well as your treat your face. Now you can, with Hand MD. For more information, visit booth #2251. Sales inquiries should contact Al Baumeler at 561.383.1102 or via email at al@synergychc.com. RXNET PROVIDES REVOLUTIONARY AUTOMATED RX PRICING FOR CHAIN PHARMACIES By Chuck Cannata, President, RxNet, Inc. Pharmacies struggling with staff discre- tionary pricing, frequent overrides, paid at U&C events, flat or shirking margins, cost increases and staying competitive in their market areas will benefit from RxNet's automated suite of pharmacy pricing. Pharmacies that purchase additional pharmacies or migrate from one pharma- cy system to another will also benefit from our services in that we can seam- lessly translate incumbent pricing to a new location or new pharmacy system without any degradation in pricing accu- racy. We deliver an automated solution that is easy to use, more than pays for itself every month, requires no staff train- ing and doesn't generate additional switch fees. We offer complete con- trol over your pric- ing and allow you to manage pricing on every drug you dis- pense for any number of locations with a single, easy to use interface. Pharmacies can expect to benefit from the implementation of our servic- es in the following ways: 1) reduced paid at U&C events and time spent reversing and resubmitting Rx's; 2) reduced repeat paid at U&C events on the same drug; 3) improved price con- sistency; 4) increased profit and mar- gin; 5) reduced overrides; 6) improved patient experience; and 7) increased more profitable cash business. We use your actual pharmacy third party experi- ences, your staff override patterns, your pre-rebate costs and market pricing from your area to deliver a comprehensive, highly effective pricing solution that is cost effective and easy to use. If you're interested in improving margins, third party pay- ments, price consistency or increasing patient count, please feel free to contact us for a no obligation evaluation. Visit RxNet at booth #1901. For more information, go to www.rxnetusa.com, call 866.506.3044 or email info@ rxnetusa.com. BIOSIG TECHNOLOGIES ANNOUNCES ADVANCED RESEARCH PROGRAM WITH MAYO CLINIC BioSig Technologies, Inc. has announced the establishment of an advanced research program with Dr. Samuel Asirvatham at Mayo Clinic in Rochester, Minnesota. This program has been designed to build upon the initial studies conducted at Mayo Clinic in March, June and November 2015 through a tripling of investment to fully characterize and devel- op novel features discovered during this prior preclinical work. These features have the potential to make a significant impact in the treatment of complex arrhythmias. "We are extremely pleased to contin- ue our sponsored research activities with Dr. Asirvatham and his colleagues at Mayo Clinic," said Greg Cash, President and Chief Executive Officer of BioSig Technologies. "The previous studies con- firmed the potential of PURE EP to improve the clarity of cardiac signals while minimizing electrical noise in the cardiac electrophysiology laboratory." About BioSig Technologies BioSig Technologies is a medical device company that is developing a proprietary technology platform designed to improve the $4 billion EP marketplace. Led by a proven management team and a veteran, independ- ent Board of Directors, Minneapolis-based BioSig Technologies is preparing to com- mercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram and intracardiac mul- tichannel signal acquisition and analysis system designed to assist electrophysiol- ogists in making clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings and providing clarity of data which may be used to guide the electrophysiologists in identifying ablation targets – areas of tissue to treat that otherwise create a heart rhythm disturbance (arrhythmia). Analysts forecast the global market for EP devices will grow at a 12.1 percent compound annual growth rate, from $2.5 billion in 2012 to $5.5 billion by 2019, making it one of the fastest growing med- ical device segments. Just in the U.S., the number of Atrial Fibrillation (AF) and Ventricular Tachycardia (VT) arrhythmia ablations is forecast to grow at 10.5 per- cent from 2012 to 2017. For more information, visit www.biosigtech.com.